About this trial
Obstructive Sleep Apnea Syndrome (OSAS) is commonly treated with CPAP devices, but adherence rates are low. Exercise has been shown to strengthen respiratory muscles, improve upper airway function, and enhance sleep quality. However, most studies have examined only single or dual exercise protocols, and there is little evidence regarding integrated programs with four exercise types or their effects when performed directly before sleep.
This project aims to develop and evaluate ApneaTheraPlay (ATP), a digital gamified video-based exercise platform combining respiratory, aerobic, strengthening, and oropharyngeal exercises. The randomized controlled, double-blind study will allocate participants into three groups: ATP, a structured pre-sleep exercise group (SPEG), and a control group (CG). Intervention groups will exercise three times per week for 12 weeks, while the control group will only keep a physical activity diary.
Eligibility criteria
Qualifiers
18-65 years of age
Individuals diagnosed with mild, moderate, or severe OSAS (AHI 5-30 events/hour) based on laboratory diagnostic polysomnography assessments
Individuals diagnosed by a pulmonologist within the last year and who have started CPAP therapy for at most 12 months and who are regular users
Those with habitual snoring
Disqualifiers
• BMI > 40 kg/m2
Serious drug or alcohol abuse
Regular use of sedatives, muscle relaxants, or opioids that may affect sleep patterns or exercise performance
Pregnancy or postpartum (<6 months) due to hormonal effects on sleep and respiratory function
Trial design
Treatments tested in this trial
- Structured Pre-Sleep Exercise
- ApneaTheraPlay (ATP)